Reconstruction of the distal tibia following resection of aggressive bone tumours using a custom-made megaprosthesis.

OBJECTIVE: Largest, single-centre study of clinical and functional outcomes of patients who underwent endoprosthetic replacement (EPR) for aggressive distal tibial bone tumours.

METHOD: Retrospective observational study of eight patients was undertaken.

RESULTS: Median follow-up was 77 months (range 13-276). Cumulative five and ten year survival was 63% and 42% respectively. Three patients developed either disease recurrence or metastases post-surgery. One patient developed deep infection requiring washout and suppressive antibiotics. No patients required revision surgery. The median MSTS score at last follow up was 66%.

CONCLUSIONS: EPR of the distal tibia is a viable option and provides good function outcomes.